SpringWorks Therapeutics, Inc.
SWTXNext catalyst
Nirogacestat oral tablet
Desmoid Tumor
Get an email about SWTX's next catalysts
Track SpringWorks Therapeutics (SWTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 0 past
Nirogacestat oral tablet Phase 2 Est. Readout
Primary completion for Nirogacestat oral tablet trial (NCT07170644) in Desmoid Tumor
SourceMarket Overview
Stock performance and key metrics
Nirogacestat oral tablet
Desmoid Tumor
Nirogacestat
Ovarian Granulosa-Stromal Tumor
High Dose Ascorbic Acid
Pancreatic Cancer
Famotidine
Covid-19
Disulfiram
Covid19
AIJP (Arnebia Indigo Jade Pearl)
Anus Neoplasms
Folfirinox
Pancreatic Cancer Metastatic
Mirdametinib (PD-0325901) oral capsule or dispersible tablet
Plexiform Neurofibroma
Nanoparticle Paclitaxel protein bound
Pancreatic Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Nirogacestat oral tablet | Phase 3 | Desmoid Tumor | - | - |
Nirogacestat | Phase 2 | Ovarian Granulosa-Stromal Tumor | - | - |
High Dose Ascorbic Acid | Phase 2 | Pancreatic Cancer | - | - |
Famotidine | Phase 2 | Covid-19 | - | - |
Disulfiram | Phase 2 | Covid19 | - | - |
AIJP (Arnebia Indigo Jade Pearl) | Phase 2 | Anus Neoplasms | - | - |
Folfirinox | Phase 2 | Pancreatic Cancer Metastatic | - | - |
Mirdametinib (PD-0325901) oral capsule or dispersible tablet | Phase 2 | Plexiform Neurofibroma | - | - |
Nanoparticle Paclitaxel protein bound | Phase 2 | Pancreatic Cancer | - | - |
Frequently asked questions
What is in SpringWorks Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 9 drug candidates in SpringWorks Therapeutics, Inc.'s (SWTX) pipeline across Phase 3, Phase 2. Its lead program is Nirogacestat oral tablet (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SpringWorks Therapeutics, Inc.'s next FDA catalyst?→
SpringWorks Therapeutics, Inc.'s (SWTX) next tracked catalyst is a Phase 2 readout expected Q2 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track SWTX biotech catalysts?→
Add SWTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SpringWorks Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.